Izotropic Corp

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

—

Div yield, %

—

Shrs. gr., 5y

13.57%

Rev. gr., 5y

Revenues

Net income

-2m

L-30.44%

CFO

-851k

L+33.75%

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Izotropic Corporation is a medical technology company focused on bringing advanced diagnostic solutions for breast cancer to market. The firm develops and sells both a specialized breast CT imaging system and a 3D CT breast imaging platform, which are designed to facilitate earlier detection and more accurate diagnosis of breast cancer. Founded in 2016, the company's operations are headquartered in Surrey, Canada.

URL

https://izocorp.com/

IPO date

May 31, 2018

Employees

Domiciled in

Incorporated in

Legal address

SUITE 2501 - 550 BURRARD ST.
Vancouver, BC V6C 2B5
CA

Headquarters

Suite 424, 800-15355 24 Avenue
Surrey, BC V4A 2H9
CA

Valuation

Order:

Title CAD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CAD in thousands, except ratios and share amounts	2026‑04	2025‑04	2024‑04	2023‑04	2022‑04	2021‑04	2020‑04	2019‑04	2018‑04	2017‑04
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT